Propofol increases agonist efficacy at the GABA(A) receptor
S M O'Shea1, L C Wong, N L Harrison
1Department of Pharmacological and Physiological Sciences, University of Chicago, IL 60637, USA.
Brain Research
|March 11, 2000
Summary
Propofol enhances the efficacy of piperidine-4-sulphonic acid (P4S) at GABA(A) receptors by facilitating gating. Midazolam, however, increases agonist binding without affecting efficacy, revealing distinct mechanisms of action for these anesthetics.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- GABA(A) receptors are crucial inhibitory neurotransmitter receptors in the brain.
- Anesthetics like propofol and midazolam modulate GABA(A) receptor activity.
- Understanding their distinct mechanisms is vital for anesthetic development.
Purpose of the Study:
- To investigate the differential effects of propofol and midazolam on GABA(A) receptor function.
- To elucidate the specific mechanisms by which these anesthetics modulate receptor activity.
Main Methods:
- Whole-cell patch-clamp electrophysiology was employed.
- HEK 293 cells expressing alpha1beta1gamma2s GABA(A) receptors were utilized.
- The effects of propofol and midazolam on the partial agonist P4S were assessed.
Main Results:
- Propofol significantly increased the efficacy of piperidine-4-sulphonic acid (P4S).
- Midazolam did not increase P4S efficacy but appeared to enhance agonist binding.
- These differential effects were observed specifically at alpha1beta1gamma2s GABA(A) receptors.
Conclusions:
- Propofol likely facilitates GABA(A) receptor gating.
- Midazolam's primary action involves increasing agonist receptor occupancy.
- These findings highlight distinct allosteric modulation mechanisms for propofol and midazolam at GABA(A) receptors.
More Related Videos
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...